Injection safety. by Luby, S.
Conference Panel Summaries
Vol. 7, No. 3 Supplement, June 2001 Emerging Infectious Diseases 535
Mathematical modeling of available epidemiologic
data suggests that each year unsafe injection practices are
responsible for 8 to 16 million persons contracting hepatitis
B virus (HBV), 2.3 to 4.7 million persons contracting
hepatitis C virus (HCV), and 80,000 to 160,000 persons
contracting HIV worldwide. In most cases, the transmis-
sion of these agents goes unrecognized because the
infection is initially subclinical.
An estimated 12 billion injections are administered
annually worldwide. Injections are not the most efficient way
to transmit HBV, HCV, and HIV, but because so many
injections are given, and enough of them are unsafe, they
account for a much larger proportion of bloodborne disease
transmission than does unsafe transfusion. Global estimates
of the percentage of unsafe injections range from 15% in
Eastern Europe to 50% throughout Asia.
Injections are popular in many settings because they
have important social meaning. Dispensing an injection
communicates that the patient’s problem is serious and that
the provider is concerned and reinforces the special status of
the healer in the community. The injection healing ritual
usually brings comfort even if it appears irrational from a
Western perspective. Because biomedical considerations do
not motivate the injection, biomedical concerns with injection
safety are often not emphasized.
Safe Injection Global Network (SIGN) was established in
October 1999 as a voluntary association of stakeholders who
share a common interest in safe and appropriate use of
injections. SIGN associates agree to collaborate with other
members for developing a common strategic framework and
communication strategy. SIGN recommends a three-part,
multidisciplinary approach to achieve safe and appropriate
use of injections. First, behavior of health care providers and
patients must be changed to decrease injection overuse and
achieve safety. Second, sufficient quantities of appropriate
injection equipment and infection control supplies should
be available. Third, a sharps waste management system
should be set up to ensure that disposable equipment is
destroyed and not reused.
Before SIGN, a number of successful efforts have reduced
injection overuse and improved safety. In Indonesia rates of
injections decreased from 73% to 14% after group discussions
between health care providers and patients. In Tanzania,
avoidable injections decreased from 16% to 6% after
guidelines to improve injection practices were developed and
communicated. In Hafizabad, Pakistan, the proportion of
injections conducted with a new sterile syringe increased
from 24% to 60% after a health education program was
conducted in mosques. Indeed, wherever a plan to promote
injection safety has been implemented, it has brought
about at least some success.
Vaccine programs are centrally important in promoting
safe injections. By adopting safe injection practices, these
programs can minimize adverse events resulting from their
own intervention. These groups can also share their
experience in developing reasonable, safe standards and
practices and help catalyze change by being high profile early
adopters of injection safety.
Persons interested in learning more about injection
safety can visit the Web site www.injectionsafety.org.
Injection Safety
Stephen Luby
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Address for correspondence: Stephen Luby, Centers for Disease
Control and Prevention, 1600 Clifton Rd., Mailstop A38, Atlanta, GA
30333 USA; fax: 404-639-2205; e-mail: sluby@cdc.gov